Mimedx Group Stock Performance
| MDXG Stock | USD 8.09 0.17 2.15% |
The company secures a Beta (Market Risk) of 0.46, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MiMedx's returns are expected to increase less than the market. However, during the bear market, the loss of holding MiMedx is expected to be smaller as well. At this point, MiMedx Group has a negative expected return of -0.18%. Please make sure to verify MiMedx's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if MiMedx Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days MiMedx Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return 2.15 | Five Day Return 1.51 | Year To Date Return (12.82) | Ten Year Return (20.69) | All Time Return 74.35 |
Last Split Date 2008-04-02 |
1 | Disposition of 61420 shares by Whitlow Ricci S of MiMedx at 8.28 subject to Rule 16b-3 | 02/13/2025 |
2 | MiMedx Group Q4 2024 Earnings Preview | 02/25/2025 |
3 | MiMedx Q4 Earnings Snapshot | 02/26/2025 |
4 | Q4 2024 MiMedx Group Inc Earnings Call Transcript | 02/27/2025 |
5 | Beyond the Balance Sheet What SWOT Reveals About MiMedx Group Inc | 02/28/2025 |
6 | Acquisition by Joseph Capper of 223268 shares of MiMedx subject to Rule 16b-3 | 03/03/2025 |
7 | Acquisition by Whitlow Ricci S of 36486 shares of MiMedx at 8.3 subject to Rule 16b-3 | 03/05/2025 |
8 | Disposition of 81446 shares by Hulse William Frank Iv of MiMedx at 7.8 subject to Rule 16b-3 | 03/10/2025 |
9 | Disposition of 4106 shares by Maersk-moller Kimberly of MiMedx at 7.89 subject to Rule 16b-3 | 03/13/2025 |
10 | Insider Selling MiMedx Group, Inc. CAO Sells 430,762.44 in Stock | 03/17/2025 |
| Begin Period Cash Flow | 82 M |
MiMedx |
MiMedx Relative Risk vs. Return Landscape
If you would invest 910.00 in MiMedx Group on December 20, 2024 and sell it today you would lose (101.00) from holding MiMedx Group or give up 11.1% of portfolio value over 90 days. MiMedx Group is currently does not generate positive expected returns and assumes 1.8135% risk (volatility on return distribution) over the 90 days horizon. In different words, 16% of stocks are less volatile than MiMedx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MiMedx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MiMedx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MiMedx Group, and traders can use it to determine the average amount a MiMedx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.101
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDXG |
Estimated Market Risk
| 1.81 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MiMedx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MiMedx by adding MiMedx to a well-diversified portfolio.
MiMedx Fundamentals Growth
MiMedx Stock prices reflect investors' perceptions of the future prospects and financial health of MiMedx, and MiMedx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MiMedx Stock performance.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 1.1 B | ||||
| Shares Outstanding | 147.37 M | ||||
| Price To Earning | 23.73 X | ||||
| Price To Book | 6.14 X | ||||
| Price To Sales | 3.35 X | ||||
| Revenue | 348.88 M | ||||
| Gross Profit | 288.81 M | ||||
| EBITDA | 64.34 M | ||||
| Net Income | 42 M | ||||
| Cash And Equivalents | 72.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 1000 K | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 3.53 X | ||||
| Book Value Per Share | 1.31 X | ||||
| Cash Flow From Operations | 66.2 M | ||||
| Earnings Per Share | 0.28 X | ||||
| Market Capitalization | 1.17 B | ||||
| Total Asset | 263.92 M | ||||
| Retained Earnings | (91.26 M) | ||||
| Working Capital | 146.29 M | ||||
| Current Asset | 96.31 M | ||||
| Current Liabilities | 26.78 M | ||||
About MiMedx Performance
By analyzing MiMedx's fundamental ratios, stakeholders can gain valuable insights into MiMedx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MiMedx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MiMedx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 144.65 | 99.54 | |
| Return On Tangible Assets | 0.18 | 0.19 | |
| Return On Capital Employed | 0.27 | 0.28 | |
| Return On Assets | 0.16 | 0.17 | |
| Return On Equity | 0.22 | 0.21 |
Things to note about MiMedx Group performance evaluation
Checking the ongoing alerts about MiMedx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MiMedx Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MiMedx Group generated a negative expected return over the last 90 days | |
| MiMedx Group is unlikely to experience financial distress in the next 2 years | |
| About 70.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Insider Selling MiMedx Group, Inc. CAO Sells 430,762.44 in Stock |
- Analyzing MiMedx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MiMedx's stock is overvalued or undervalued compared to its peers.
- Examining MiMedx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MiMedx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MiMedx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MiMedx's stock. These opinions can provide insight into MiMedx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets |